logo

For the Inventor, By the Inventor

Mino, Japan

Tamio Sugawara

This inventor holds 6 USPTO granted patents, plus 1 CIPO patent. Top assignee: Shionogi Company Limited. Active years: 1980-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tamio Sugawara. Retrieved from https://idiyas.com/inventor/tamio-sugawara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0


Average Co-Inventor Count = 2.7

ph-index = 6

Forward Citations = 73(Granted Patents)


Location History:

  • Mino, JP (1980 - 1983)
  • Sanda, JP (2000)
  • Hyogo, JP (2001)

Company Filing History:

goldMedal6 out of 1,001 
 
Shionogi Company Limited
 patents

Years Active: 1980-2001

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents
1. 6319902 - Peptide derivatives having thiazolyl-alanine residue (2001-11-20),
2. 6054591 - Lymph-absorbable aryl substituted imidazole derivatives (2000-04-25),
3. 4370475 - Apramycin derivatives (1983-01-25),
4. 4358585 - 5-Deoxyapramycin (1982-11-09),
5. 4273923 - Process for preparing aminoglycoside derivatives (1981-06-16),
6. 4201774 - Novel aminoglycoside derivatives (1980-05-06),

Title: The Innovations of Tamio Sugawara

Introduction

Tamio Sugawara is a notable inventor based in Mino, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative peptide derivatives. With a total of 6 patents to his name, Sugawara continues to push the boundaries of scientific research and development.

Latest Patents

Among his latest patents, Sugawara has developed peptide derivatives that feature a thiazolyl-alanine residue. This invention includes a peptide derivation of the formula (I) or its pharmaceutically acceptable salt or hydrate. Additionally, he has created lymph-absorbable aryl substituted imidazole derivatives, which further showcase his expertise in medicinal chemistry.

Career Highlights

Sugawara is currently associated with Shionogi Company Limited, a prominent pharmaceutical company known for its commitment to research and development. His work at Shionogi has allowed him to focus on creating innovative solutions that address various health challenges.

Collaborations

Throughout his career, Sugawara has collaborated with esteemed colleagues such as Kikuo Igarashi and Tsunetoshi Honma. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Tamio Sugawara's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a leading inventor. His innovative work continues to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…